SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2025 quarter is pegged at Rs. 3490.00 millions, about 16.21% up against Rs. 3003.10 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2025 is Rs. -174.20 millions as compared to Net Profit of Rs. 81.00 millions of corresponding quarter ended December 2024The company reported a degrowth in operating Profit to 373.50 millions from 591.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 3490.00 3003.10 16.21 9816.90 10107.50 -2.88 12837.60 12889.20 -0.40
Other Income 0.00 14.90 0.00 14.70 31.90 -53.92 91.40 53.70 70.20
PBIDT 373.50 591.80 -36.89 1306.00 1644.40 -20.58 2129.80 -896.90 -337.46
Interest 224.50 265.40 -15.41 671.80 856.90 -21.60 1148.10 1059.70 8.34
PBDT 81.50 326.40 -75.03 566.70 787.50 -28.04 981.70 -3853.00 -125.48
Depreciation 255.70 245.40 4.20 736.40 749.50 -1.75 992.50 1030.30 -3.67
PBT -174.20 81.00 -315.06 -169.70 38.00 -546.58 -10.80 -4883.30 -99.78
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 785.40 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 785.40 0.00
PAT -174.20 81.00 -315.06 -169.70 38.00 -546.58 -10.80 -5668.70 -99.81
Equity 444.90 402.50 10.53 444.90 402.50 10.53 402.50 360.00 11.81
PBIDTM(%) 10.70 19.71 -45.69 13.30 16.27 -18.23 16.59 -6.96 -338.42

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×